v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense
The following is a summary of stock-based compensation expense we recorded during the respective periods:
  
Year Ended December 31,
 202420232022
 (in thousands)
Selling, general and administrative expenses$50,668 $40,751 $45,214 
Corporate expenses59,680 75,208 64,835 
Total $110,348 $115,959 $110,049 
Summary of Stock Options Activity
The following table presents a summary of our stock options outstanding at the dates given, and stock option activity for the period between such dates (“Price” reflects the weighted average exercise price per share):  
Year Ended December 31,
 202420232022
     Options    Price    Options    Price    Options    Price
 (in thousands, except per share data)
Outstanding January 12,366 $32.85 3,257 $29.78 7,720 $18.24 
Exercised(851)30.57 (891)21.63 (4,461)9.79 
Forfeited or expired
(1)63.29 — — (2)70.26 
Outstanding December 311,514 $34.12 2,366 $32.85 3,257 $29.78 
Exercisable December 311,513 $34.09 2,362 $32.78 3,171 $29.02 
Weighted average fair value per option granted$— $—  $— 
Summary of Stock Options, by Range of Exercise Price Vesting dates on the stock options is March 2025, and expiration dates range from January 2025 to March 2031 at exercise prices and average contractual lives as follows:
Range of
Exercise
Prices		Outstanding
as of
12/31/24		Weighted
Average
Remaining
Contractual
Life
Weighted
Average
Exercise
Price 
Exercisable
as of
12/31/24		Weighted
Average
Remaining
Contractual
Life		Weighted
Average
Exercise
Price
(in thousands) 
(in years) 
(in thousands) 
(in years) 
$15.00 - $19.99
510 1.1$19.36 510 1.1$19.36 
$20.00 - $24.99
5 1.3$23.43 5 1.3$23.43 
$25.00 - $29.99
484 2.2$28.99 484 2.2$28.99 
$30.00 - $44.99
145 3.2$44.05 145 3.2$44.05 
$45.00 - $60.99
357 4.2$56.79 357 4.2$56.79 
$61.00 - $89.99
13 6.0$74.39 12 6.0$73.19 
Summary of Unvested Restricted Stock Activity
The following table presents a summary of our unvested restricted stock awards outstanding at December 31, 2024, 2023 and 2022 (“Price” reflects the weighted average share price at the date of grant):
 
Restricted Stock
 AwardsPrice
 (in thousands, except per share data)
Unvested at December 31, 2021860 $78.48 
Granted2,002 103.34 
Forfeited(22)80.57 
Vested(1,844)99.68 
Unvested at December 31, 2022996 $89.22 
Granted841 70.51 
Forfeited(7)92.06 
Vested(357)89.93 
Unvested at December 31, 20231,473 $78.34 
Granted749 96.49 
Forfeited(32)85.51 
Vested(710)81.84 
Unvested at December 31, 20241,480 $85.70 
Assumptions Used to Calculate Fair Value of Deferred Stock Awards
The following assumptions were used to calculate the fair value of the deferred stock awards with market conditions on the date of grant:
 
Year Ended December 31,
 202420232022
Risk-free interest rate4.17 %4.47 %
2.85% - 3.69%
Volatility factors40.57 %39.33 %
45.10% - 45.99%
Weighted average expected life (in years)4.845.225.27
Summary of Deferred Stock Activity
The following table presents a summary of our unvested deferred stock awards outstanding at December 31, 2024, 2023 and 2022 (“Price” reflects the weighted average grant date fair value):
Deferred Stock
AwardsPrice
(in thousands, except per share data)
Unvested at December 31, 20212,192 $26.56 
Awarded2,160 59.79 
Forfeited— — 
Vested(2,192)26.56 
Unvested at December 31, 20222,160 $59.79 
Awarded289 70.47 
Forfeited— — 
Vested— — 
Unvested at December 31, 20232,449 $61.05 
Awarded33 76.61 
Forfeited— — 
Vested(486)66.87 
Unvested at December 31, 20241,996 $59.89